| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Chief Development Officer
1 company
Christopher Yea is Chief Development Officer at KALV. From November 2016 to November 2025, the filings on record show 0 open-market purchases and 38 sales. Christopher Yea's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.0M at current prices.
Historically, Christopher Yea's trades have earned a middling insider score of 53/100 across 27 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -21.6%.
The KALV filings lean toward selling, a net 238,603 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,604 | $10.14 | $26,416.02 | -6.5% | +3.7% | +14.6% | |
| Feb 17, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,727 | $7.66 | $20,888.82 | -7.1% | +28.1% | +83.0% | |
| Nov 18, 2022 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,139 | $5.44 | $6,196.16 | -3.2% | +49.7% | +59.5% | |
| Aug 17, 2022 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,145 | $14.96 | $17,130.00 | -3.3% | -65.7% | -28.1% | |
| Nov 1, 2021 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 5,000 | $18.07 | $90,328.00 | -13.2% | -30.8% | -72.1% | |
| Aug 2, 2021 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 5,000 | $20.52 | $102,578.50 | -11.6% | -10.8% | -40.4% | |
| May 3, 2021 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 5,000 | $24.84 | $124,196.50 | -10.4% | -18.1% | -47.4% | |
| Feb 23, 2021 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 15,000 | $33.59 | $503,877.32 | -23.8% | - | - | |
| Oct 29, 2020 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 5,000 | $17.48 | $87,394.00 | -7.4% | - | - | |
| Oct 21, 2020 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 13,986 | $17.82 | $249,167.38 | -17.1% | - | - |